A giant MS plaque mimicking PML during natalizumab treatment-Reference-Cited by-同舟云学术

A giant MS plaque mimicking PML during natalizumab treatment

Published:2010-04 Issue:1-2 Volume:291 Page:110-113
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Twyman Cary,Berger Joseph R.

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology

Reference12 articles.

1. Benstetter, M. Meeting highlights from the Committee for Medicinal Products for Human Use, 19–22 October 2009. Press Release 2009 [cited 2009 October 24]; Available from: http://www.emea.europa.eu/pdfs/human/press/pr/67119009en.pdf.

2. Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy;Yousry;N Engl J Med,2006

3. Progressive multifocal leukoencephalopathy: lessons from AIDS and natalizumab;Berger;Neurol Res,2006

4. Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function;Khatri;Neurology,2009

5. Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients;Kepes;Ann Neurol,1993

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paradoxical Tumefactive Worsening of Multiple Sclerosis After Natalizumab Initiation: A Case Report;US Neurology;2023

2. Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases;Therapeutic Advances in Neurological Disorders;2021-01

3. Pharmacovigilance during treatment of multiple sclerosis: early recognition of CNS complications;Journal of Neurology, Neurosurgery & Psychiatry;2020-11-23

4. Acute multiple sclerosis lesion pathology does not predict subsequent clinical course—a biopsy study;Irish Journal of Medical Science (1971 -);2019-02-15

5. Tumefactive multiple sclerosis lesions associated with fingolimod treatment: Report of 5 cases;Multiple Sclerosis and Related Disorders;2018-10